CClinicalTrials.gg
WithdrawnNCT04236661ReSQuTheVetsUpdated Aug 7, 2020

Reports on Sleep Quality and Thermoregulation Among Veterans

An interventional study of chilipad in Sleep Disturbance, sponsored by Wake Forest University Health Sciences. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-08-07.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Treatment

Why this study was withdrawn
study team unable to start up study at this time
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

To assess and compare the quality of sleep self- reported by veterans with sleep disorders before and after use of the Chilipad cooling mattress pad

Read the detailed description

A non-randomized convenience sampling study of N=20 adult male or female veterans (> 18 years of age) with self-reporting sleep disturbance and will utilize a Chilipad cooling mattress for the 5-week study period

02

Conditions studied

  • Sleep Disturbance

Keywords

  • chilipad
  • Sleep disorders
03

In context

Dyssomnias

324 studies on the registry are indexed under Dyssomnias; 51 are open to participants now.

Browse Dyssomnias studies →

Lead sponsor

Wake Forest University Health Sciences is the lead sponsor of 1,320 studies on the registry; 199 are open to participants now.

Of its 323 completed or terminated interventional studies of FDA-regulated products, 243 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult male and female veteran patients (> 18 years of age)
  • Self-report of sleep disturbance, defined as "sleep of poor quality, timing, efficiency, or duration"

Exclusion criteria

Exclusion Criteria:

  • Non-adult patients \< 18 years of age.
  • Patients with chart documentation or self-report of illegal drug use, impaired orientation and cognition or currently incarcerated.
  • Initiated CAM or non-CAM treatments for sleep disturbance in the last 4 weeks.
  • Changed dose of a CAM or non-CAM treatments for sleep disturbance in the last 4 weeks.
  • Initiated antidepressants in the last 3 months.
  • Changed of an antidepressant in the last 3 months.
  • Patients who describe their health as fair or poor.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Chilipad Arm

    Subjects will use chilipad nightly for 5 weeks

    Device: chilipad

Interventions

  • Devicechilipad

    Chilipad is a commercially available pad designed to be placed between the top of a mattress and bed sheets. It allows for precise temperature regulation in one's bed.

06

What researchers measure

Primary outcomes

  1. PROMIS Sleep Related Impairment Short Form

    PROMIS sleep related impairment short form is a questionnaire with 8-item 5-point Likert rating scale survey reflecting DSM-5 for sleep disturbance. The raw score on 8 items is determined, summed for a raw score, then a T-score table is utilized to compare with the subject's individual score. The result, rounded to the nearest whole number determines the score. The survey T-scores are interpreted as: \< 55 = none to slight; 55.0 - 59.9 = mild; 60.0 - 69.9 = moderate; and \> 70 = severe

    Time frame: 5-week prior intervention

  2. PROMIS Sleep Related Impairment Short Form

    PROMIS sleep related impairment short form is a questionnaire with 8-item 5-point Likert rating scale survey reflecting DSM-5 for sleep disturbance. The raw score on 8 items is determined, summed for a raw score, then a T-score table is utilized to compare with the subject's individual score. The result, rounded to the nearest whole number determines the score. The survey T-scores are interpreted as: \< 55 = none to slight; 55.0 - 59.9 = mild; 60.0 - 69.9 = moderate; and \> 70 = severe

    Time frame: 5-week after intervention

Secondary outcomes

  1. OURA ring total sleep metric

    OURA is a ring that is worn on a finger and collects information about the quality and duration of sleep. The total sleep metric will show hours of sleep each night.

    Time frame: Nightly for 5 weeks

  2. OURA ring REM metric

    OURA is a ring that is worn on a finger and collects information about the quality and duration of sleep. The total REM metric will show the total amount of REM sleep each night.

    Time frame: Nightly for 5 weeks

  3. OURA ring DEEP sleep metric

    OURA is a ring that is worn on a finger and collects information about the quality and duration of sleep. The DEEP sleep metric will show the number of hours of deep sleep each night.

    Time frame: Nightly for 5 weeks

  4. OURA ring Efficiency metric

    OURA is a ring that is worn on a finger and collects information about the quality and duration of sleep. Efficiency means the percentage of time spent sleeping while in bed.

    Time frame: Nightly for 5 weeks

  5. OURA ring latency metric

    OURA is a ring that is worn on a finger and collects information about the quality and duration of sleep. Latency is the amount of time it takes a study participant to fall to sleep.

    Time frame: Nightly for 5 weeks

  6. OURA ring timing metric

    OURA is a ring that is worn on a finger and collects information about the quality and duration of sleep. The timing records individual circadian rhythms.

    Time frame: Nightly for 5 weeks

  7. OURA ring sleep score metric

    OURA is a ring that is worn on a finger and collects information about the quality and duration of sleep. The sleep score metric will be determined by total sleep, efficiency, disturbances, REM sleep, deep sleep, sleep latency, sleep timing and light sleep.The sleep score ranges from 0-100. Higher scores denotes better outcomes.

    Time frame: Nightly for 5 weeks

  8. OURA ring resting heart rate

    OURA is a ring that is worn on a finger and collects information about the quality and duration of sleep. The resting heart rate will be recorded.

    Time frame: Nightly for 5 weeks

  9. OURA ring respiration rate

    OURA is a ring that is worn on a finger and collects information about the quality and duration of sleep. The respiration rate will be recorded.

    Time frame: Nightly for 5 weeks

  10. OURA ring readiness score

    OURA is a ring that is worn on a finger and collects information about the quality and duration of sleep. The readiness score is calculated taking in account sleep balance, previous day activity, activity balance, body temperature, resting heart rate (rhr), recovery index . Score will be between 0 and 100. A lower score indicates a worse outcome.

    Time frame: Nightly for 5 weeks

  11. OURA ring Skin temperature

    OURA is a ring that is worn on a finger and collects information about the quality and duration of sleep. The OURA ring will measure skin temperature.

    Time frame: Nightly for 5 weeks

07

Study locations

1 site
  • Wake Forest Baptist Health
    Winston-Salem, North Carolina 27157, United States
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04236661
Lead sponsor
Wake Forest University Health Sciences
Responsible party
Sponsor
First posted
Jan 22, 2020
Start date
Jul 2020 (estimated)
Primary completion
Nov 2020 (estimated)
Completion
Nov 2020 (estimated)
Last update
Aug 7, 2020

Study contacts

Remy Coeytaux, MD, PhD
principal investigator · Wake Forest University Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion